```html

Touch Sensitivity (Allodynia & Hyperesthesia)

What is Touch Sensitivity?

Touch sensitivity refers to an abnormal or heightened response to tactile stimuli that are normally non‑painful. The medical literature often distinguishes two related terms:

• Allodynia – pain caused by a stimulus that does not normally provoke pain (e.g., a light brush of cloth feels like burning).
• Hyperesthesia – an increased intensity of normal sensations, which may be uncomfortable but not always painful.

People describing “touch sensitivity” may use either term, or simply say that their skin feels “oversensitive,” “tingly,” “prickly,” or “stinging” when touched lightly. The symptom can be localized (affecting a single limb or area) or generalized (affecting large skin regions). It is a common neurological complaint and can be a sign of many different medical conditions.

Common Causes

Touch sensitivity is not a disease itself; it is a symptom of an underlying process. Below are the most frequently encountered causes, organized by system.

Neurologic Conditions

• Peripheral neuropathy – damage to peripheral nerves from diabetes, alcohol, chemotherapy, or vitamin deficiencies.
• Complex regional pain syndrome (CRPS) – a chronic pain condition that often follows an injury and causes intense allodynia.
• Multiple sclerosis (MS) – demyelination in the central nervous system can produce sensory disturbances including tactile hyper‑sensitivity.
• Post‑herpetic neuralgia – lingering nerve damage after shingles (herpes zoster) infection.
• Fibromyalgia – a centralized pain syndrome characterized by widespread hyper‑sensitivity to touch, pressure, and temperature.

Inflammatory & Autoimmune Disorders

• Lupus (systemic or cutaneous) – immune‑mediated inflammation of skin and nerves.
• Rheumatoid arthritis – joint inflammation can irritate surrounding nerves, especially in the hands.
• Vasculitis – inflammation of blood vessels supplying nerves, leading to sensory changes.

Infectious & Post‑Infectious States

• Lyme disease – tick‑borne infection that may cause peripheral neuropathy.
• COVID‑19 and long‑COVID – reports of persistent dysesthesia, including touch sensitivity, after infection.
• HIV neuropathy – chronic viral infection can damage peripheral nerves.

Other Causes

• Medications – some antiretrovirals, chemotherapy agents (e.g., taxanes, vincristine), and certain antibiotics cause neurotoxic sensory side‑effects.
• Trauma or surgery – nerve compression, scar tissue, or postoperative complications may produce localized allodynia.
• Skin conditions – eczema, psoriasis, or contact dermatitis can make the skin unusually sensitive to mechanical pressure.
• Psychogenic factors – anxiety, depression, or somatic symptom disorder can amplify normal tactile sensations.

Associated Symptoms

The presence of additional signs helps narrow the cause. Commonly reported companions of touch sensitivity include:

• Pain that is burning, stabbing, or throbbing.
• Tingling or “pins‑and‑needles” (paresthesia).
• Numbness or loss of sensation in the same area.
• Swelling, redness, or warmth over the affected region.
• Muscle weakness or clumsiness.
• Fatigue, sleep disturbances, and mood changes (often seen in fibromyalgia).
• Systemic signs such as fever, weight loss, or rash (suggesting infection or autoimmune disease).
• Changes in skin texture (e.g., thickening, ulceration) when the underlying condition is chronic.

When to See a Doctor

Touch sensitivity can be benign (e.g., after a minor bruise) but may also signal serious disease. Seek medical attention promptly if you experience any of the following:

• Sudden onset of severe pain with a light touch.
• Progressive spreading of the sensitivity beyond the original area.
• Associated weakness, loss of coordination, or difficulty walking.
• Accompanying fever, chills, unexplained weight loss, or night sweats.
• New symptoms after starting a medication or chemotherapy.
• Symptoms that interfere with daily activities, sleep, or ability to work.
• History of diabetes, autoimmune disease, or recent infection and a new sensory change.

Diagnosis

Evaluating touch sensitivity involves a combination of history‑taking, physical examination, and targeted testing.

History

• Onset, duration, and pattern (constant vs. intermittent).
• Location(s) and whether it is unilateral or bilateral.
• Recent injuries, surgeries, infections, or medication changes.
• Medical background (diabetes, autoimmune disease, cancer, etc.).
• Associated symptoms (pain type, numbness, systemic signs).

Physical Examination

• Neurologic exam – testing light touch, pinprick, vibration, and proprioception.
• Assessment for skin changes, edema, and temperature differences.
• Musculoskeletal exam – checking for joint swelling or range‑of‑motion limitations.

Diagnostic Tests

• Electrodiagnostic studies (NCS/EMG) – evaluate peripheral nerve function.
• Quantitative Sensory Testing (QST) – measures thresholds for touch, heat, and cold.
• Blood work – CBC, fasting glucose, HbA1c, Vitamin B12, thyroid panel, inflammatory markers (ESR, CRP), autoimmune panels (ANA, RF, anti‑CCP).
• Imaging – MRI of the brain or spine if central lesions (MS, tumor) are suspected; ultrasound or X‑ray for peripheral entrapment.
• Skin biopsy – in select cases to assess small‑fiber neuropathy.
• Infectious work‑up – Lyme serology, HIV screen, COVID‑19 PCR/antibody if recent illness.

Treatment Options

Treatment is directed at the underlying cause and at symptom relief. An individualized plan often combines medication, physical therapy, and lifestyle measures.

Medical Therapies

• Neuropathic pain agents – gabapentin, pregabalin, duloxetine, or tricyclic antidepressants. These drugs modulate nerve signaling and are first‑line for many neuropathies.
• Topical agents – lidocaine 5% patches or 4% creams, capsaicin 8% patches for localized allodynia.
• Anti‑inflammatory drugs – NSAIDs for inflammatory conditions; corticosteroids for acute flare‑ups of autoimmune disease or post‑herpetic neuralgia.
• Disease‑modifying therapies – disease‑modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis, disease‑modifying agents for multiple sclerosis, or antibiotics for Lyme disease.
• Antiviral therapy – early treatment of shingles with acyclovir, valacyclovir, or famciclovir can reduce the risk of post‑herpetic neuralgia.
• Opioids – generally avoided due to risk of dependence; reserved for severe, refractory pain under specialist supervision.
• Physical medicine & rehabilitation – nerve blocks, sympathetic blocks, or spinal cord stimulation for refractory CRPS.

**Key Sources:** Mayo Clinic, Cleveland Clinic, NIH Neurology, CDC (Lyme & COVID‑19), WHO (pain management).

Home & Self‑Management Strategies

• Temperature regulation – avoid extreme heat or cold; cool compresses can soothe burning sensations.
• Gentle skin care – use fragrance‑free moisturizers, avoid tight clothing, and wear soft fabrics (cotton, silk).
• Gradual desensitization – under a therapist’s guidance, gently increase exposure to light touch to retrain sensory pathways.
• Stress reduction – mindfulness, meditation, or yoga may lower central sensitization.
• Balanced nutrition – adequate B‑vitamins, omega‑3 fatty acids, and antioxidants support nerve health.
• Regular exercise – low‑impact activities (walking, swimming) improve circulation and reduce neuropathic pain.
• Foot care – for diabetic neuropathy, inspect feet daily, keep nails trimmed, and use padded shoes to avoid trauma.

Prevention Tips

While some causes (genetics, unavoidable illness) cannot be prevented, many risk factors are modifiable.

• Maintain optimal blood sugar levels if you have diabetes – target HbA1c <7% (per ADA guidelines).
• Protect skin from burns, cuts, and repeated friction; use barrier creams for occupational exposure.
• Practice safe sun protection to reduce skin inflammation that can heighten sensitivity.
• Follow vaccination schedules (e.g., shingles vaccine for adults ≥50) to lower risk of post‑herpetic neuralgia.
• Avoid excessive alcohol consumption – >14 drinks/week increases neuropathy risk.
• Use protective equipment (gloves, padding) when handling vibrating tools or heavy machinery.
• Stay current with tick‑bite prevention (insect repellent, long clothing) in endemic areas for Lyme disease.
• Review medication side‑effects with your clinician; ask about alternative agents if you develop sensory changes.

Emergency Warning Signs

---

References: Mayo Clinic. “Allodynia.” 2023; CDC. “Lyme Disease.” 2022; National Institute of Neurological Disorders and Stroke. “Peripheral Neuropathy Fact Sheet.” 2021; Cleveland Clinic. “Complex Regional Pain Syndrome.” 2022; WHO. “Pain Management.” 2020.

```